education
Small continuing education for the health professions (CEHP) teams are not uncommon. In fact, in 2020, the Alliance Research Committee published the results of their survey of Alliance members regarding the most significant barriers they face in...
By: Katie West, M.S.N., R.N.
education
Around 7% of people in the U.S. identify as LGBTQ+1, with over 1 million same-sex couples2 and 1.6 million transgender people.3 A 2021 survey indicated that Gen Z — people born between 1997 and 2004 — are mostly likely to identify as...
By: Rachel Every, RN, BSN; Chris Napolitan; and Tricia Wilson, MS, CHCP
leadership
How do clinicians know if they are treating patients too much, too little or just right? As continuing professional education (CPE) professionals, we focus on providing access to education that helps clinicians balance evidence-based science with...
By: Alana Brody, MBA, CHCP; and Susan Miller, Ph.D.
leadership
Medical writers are vital partners in creating high-quality, evidence-based content for continuing medical education/continuing professional development (CME/CPD) activities and programs. Writers who specialize in CME/CPD often have a clinical,...
By: Alexandra Howson, PhD, CHCP
outcomes
In 2019, an emerging therapy showing promising results in breast cancers with low levels of HER2 began to emerge, indicating significant changes would need to be made in the testing, reporting and tracking of a patient’s HER2 status.
By: Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA; and Kellie Beumer, MBA
education
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is a chronic and recurrent inflammatory disease of the intestinal tract that currently affects as many as three million Americans.
By: Elizabeth Johnson, MA; Nicolette Theriault, MPH; and Lobna Eldasher, PharmD
outcomes
Our forward-focused conversation continues with this third installment in a series focused on Advancing Continuing Medical Education (CME*). Most recently, our article focused on team-based education and the importance of design.
By: Sarah Nisly, PharmD, MEd, BCPS, FCCP; Caroline Pardo, PhD, CHCP, FACEHP; Cody Ortmann
education
Though it’s common knowledge that there is a lack of diversity in clinical trials, a glance at the actual statistics on the subject is still quite startling. A recent study published in THE LANCET Regional Health found that of 4.76 million...
By: Tariqa Ackbarali, MS, PhD
outcomes
While the rapidly evolving field of immuno-oncology (I-O) has precipitated unprecedented advancements in cancer treatment, there are significant clinical gaps related to I-O biomarker testing and patient care.
By: Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA, FACEHP, CPHQ; and Kellie Beumer